Saliva testing may reveal early signs of diabetes and obesity

(Press-News.org) Measuring elevated levels of insulin in blood, called hyperinsulinemia, is a proven way to measure metabolic health and can show risk of developing future health concerns, including Type 2 diabetes, obesity and heart disease.

Now, a team of UBC Okanagan researchers has found that measuring insulin levels in saliva offers a non-invasive way to do the same test—without the need for needles or lab-based blood work.

Dr. Jonathan Little, Professor with UBC Okanagan’s School of Health and Exercise Sciences, says that a simple spit test goes a bit further. It can also be used to detect early metabolic changes linked to obesity and other health risks.

The study, recently published in Applied Physiology, Nutrition, and Metabolism, included 94 healthy participants with a range of body sizes. After a period of fasting, each participant drank a standardized meal-replacement shake, then provided saliva samples and underwent a finger-prick blood glucose test.

“People living with obesity had much higher insulin levels in their saliva than those who were slightly overweight or had lower body weight—even though their blood sugar levels were the same,” he says. “This suggests that saliva testing could be a simple, non-invasive way to identify people at risk of Type 2 diabetes before symptoms appear.”

Type 2 diabetes affects about 400 million people worldwide and is diagnosed by high blood glucose levels. But Dr. Little notes that prediabetes conditions—such as insulin resistance and hyperinsulinemia—may develop 10 to 20 years before a person is diagnosed.

“If hyperinsulinemia can be detected before blood glucose levels start to rise, people at risk for Type 2 diabetes could be identified early, allowing for lifestyle changes and other treatments to be introduced long before glucose levels rise.”

Taking preventive steps at an early stage is important because hyperinsulinemia is a known predictor of several chronic conditions, including Type 2 diabetes, hypertension, cardiovascular disease, stroke, cancer, and most recently, it has been linked to obesity.

Co-author Dr. Hossein Rafiei explains that the study aimed to help develop a practical non-invasive test for hyperinsulinemia, but they also found an interesting result following the consumption of the meal-replacement drink.

Dr. Rafiei’s previous research at UBC Okanagan showed that saliva insulin levels closely follow plasma insulin levels across the day following high and low-carbohydrate mixed meals.

“This suggests that saliva insulin may help distinguish between high and low plasma insulin responses, and could play a role in predicting the severity of hyperinsulinemia and possibly insulin resistance.”

During the study, participants provided saliva tests 30, 60 and 90-minutes after drinking the beverage.

Dr. Rafiei notes that, interestingly, some participants with lower body weight also experienced large saliva insulin spikes after the meal. This suggests they may be at heightened risk for Type 2 diabetes, even without excess weight and having normal blood glucose levels.

“The finding that some people who are lean have high insulin is intriguing,” says Dr. Rafiei. “This indicates that saliva insulin may be more useful than measuring someone’s weight or waist size.”

The study also looked at the relationship between waist circumference, BMI, age and sex, and found that waist size had the strongest link to saliva insulin levels.

“These findings suggest that waist circumference could be a more reliable indicator of hyperinsulinemia than age or overall body weight when using saliva insulin,” he says. “Our results also suggest that saliva insulin may be better than blood glucose at distinguishing between those who are more metabolically healthy and those who are more likely to live with hyperinsulinemia.”

END